Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
EXEL
#736
Exelixis, Inc. - Common Stock
56.3
5
USD
+0.01%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.44%
Monthly Change
+8.16%
6 month change
+30.62%
Year Change
+44.34%
Previous Close
55.5
5
Open
55.5
5
Low
55.2
9
High
56.5
0
Volume
362
Markets
US Stock Market
Healthcare
Biotechnology
EXEL
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q1, 25
Total assets
2.59 B
Total liabilities
657.85 M
Total equity
1.94 B
Total liabilities & shareholders' equities
2.59 B
Total debt
—
Net debt
—
News
J&J Q2 Earnings Beat on Darzalex, Tremfya Growth, 2026 Outlook Raised
Macro Note: The Tech Unwind Grew A Second Leg, And It’s Healthcare
Zacks Investment Ideas feature highlights: XLV, XBI, LLY, EXEL, PTCT, FTRE and ILMN
EXEL Stock Soars 26.8% in Three Months: Is There More Room for Growth?
Stocks Look Shaky, But This Sector is Booming (Biotech)
Here's Why Exelixis (EXEL) is a Strong Growth Stock
Exelixis: STELLAR-303 Results Mixed, STELLAR-304 Success Likely (NASDAQ:EXEL)
EXEL vs. ILMN: Which Stock Should Value Investors Buy Now?
Exelixis, Inc. (EXEL) Hit a 52 Week High, Can the Run Continue?
Axsome Therapeutics, Exelixis, Incyte Among 20 New Stocks On IBD's Premier Watchlists
Arista Networks, Morgan Stanley Among 15 New Stocks On IBD Watchlists
Why Exelixis (EXEL) is a Top Value Stock for the Long-Term